LFVN Stock Analysis: Buy, Sell, or Hold?

LFVN - Lifevantage Corporation Common Stock (Delaware)

PHARMACEUTICAL PREPARATIONS
$4.31
0.01 (0.23%) โ–ฒ
5d: -5.07%
30d: -7.31%
90d: -29.0%
HOLD
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 05, 2026

Get Alerted When LFVN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

๐Ÿ’ก
Bottom Line:
๐Ÿ“Š HOLD: LFVN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$3.34
Based on -2.5% avg growth
INTRINSIC VALUE TODAY
$2.07
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.2x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: LFVN is currently trading at $4.31, which is considered oversold relative to its 30-day fair value range of $4.45 to $5.04. From a valuation perspective, the stock is trading at a premium (Forward PE: 7.0) compared to its historical average (6.2). At these levels, the market is pricing in 4.1% annual earnings growth.

Technical Outlook: Technically, LFVN is in a strong downtrend. Immediate support is located at $4.07, while resistance sits at $5.23.

Market Sentiment: LFVN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+86.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $4.45 - $5.04
Company Quality Score 49/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 60.5%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 86.0% below Wall St target ($8.00)
  • BULLISH: Expecting earnings turnaround to 4.1% growth with -27.8% revenue growth
  • CAUTION: Recommendation downgraded due to -5.1% 5-day decline

Fair Price Analysis

30-Day Fair Range $4.45 - $5.04
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $4.07
Resistance Level $5.23
Current Trend Strong Downtrend
Technical data as of Mar 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 7.01
Wall Street Target $8.00 (+86.0%)
Revenue Growth (YoY) -27.8%
Earnings Growth (YoY) -89.5%
Profit Margin 3.7%
Valuation Premium vs History +4.1% premium
PE vs Historical 7.0 vs 6.2 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +4.1% (market-implied from PE analysis)
1-Year Target $4.48 (+4%)
2-Year Target $4.66 (+8%)
3-Year Target $4.85 (+13%)
3-Yr Target (if PE normalizes) (PE: 7โ†’6) PE COMPRESSION $4.29 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.4, Growth: -8.9%) $10.38 (+142%)
Base: (SPY PE: 7.0, Growth: -8.9%) $3.25 (-24%)
Bear: (PE: 6.0, Growth: -8.9%) $2.76 (-36%)
๐Ÿ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (8x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 7.78 | Current EPS (TTM): $0.60
Bull Case $5.25 (+16%)
Analyst growth 2.2%, PE expands to 8.6
Base Case $4.77 (+5%)
Market implied 2.2%, PE stable at 7.8
Bear Case $3.18 (-30%)
Severe decline -20.0%, PE contracts to 6.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 12:23 PM ET
Data refreshes hourly during market hours. Next update: 1:23 PM
๐Ÿ”ฅ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
6
Buys
3
Sells
+
Net
INSIDERS SELLING
Recent Transactions
Darwin Lewis BUY 1055 shares 2026-03-16
Judd Dayton BUY 10500 shares 2026-03-02
Judd Dayton BUY 18097 shares 2026-02-27

Unlock Insider Activity

See real-time buying/selling by company executives for LFVN.

Create Free Account

Already have an account? Log In

Top Rated Packaged Foods Stocks

Top-rated stocks in Packaged Foods by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
FRPT
Freshpet Inc
STRONG BUY
19 analysts
$87 52 HOLD
DAR
Darling Ingredients Inc
STRONG BUY
13 analysts
$62 58 HOLD
BRBR
Bellring Brands LLC
STRONG BUY
17 analysts
$30 45 HOLD
NOMD
Nomad Foods Ltd
STRONG BUY
7 analysts
$14 62 BUY
CPB
Campbellโ€™s Co
SELL
23 analysts
$26 55 HOLD

More Analysis for LFVN

LFVN Technical Chart LFVN Price Prediction LFVN Earnings Date LFVN Investment Advisor LFVN Fair Price Analyzer LFVN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals